Matches in Nanopublications for { ?s ?p "[Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_assertion description "[Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_provenance.
- NP618610.RAiRqDiQClOEZHmBZhEyWKNHhazIeqlT1XjQ3eRjV2mt0130_assertion description "[Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618610.RAiRqDiQClOEZHmBZhEyWKNHhazIeqlT1XjQ3eRjV2mt0130_provenance.